Late last month, the Association of Corporate Counsel (ACC) hosted a panel on artificial intelligence and how it is rapidly transforming the life sciences sector, allowing companies to leverage large datasets to accelerate...more
5/2/2024
/ Artificial Intelligence ,
Clinical Trials ,
Consent ,
EU ,
General Data Protection Regulation (GDPR) ,
Life Sciences ,
Personal Data ,
Pharmaceutical Industry ,
Privacy Notice Rule ,
Public Interest ,
Research and Development ,
Transparency
In the last ten years, more data and greater computing power have led to a boom in AI-related patent applications, with life and medical sciences emerging as a top application field. In 2021, more than 100 applications...more
6/1/2023
/ Artificial Intelligence ,
Biotechnology ,
Center for Drug Evaluation and Research (CDER) ,
Corporate Counsel ,
Emerging Technologies ,
Food and Drug Administration (FDA) ,
Life Sciences ,
Machine Learning ,
PHI ,
Regulatory Agenda ,
Research and Development ,
State Privacy Laws ,
USDA
Earlier this month, the ACC hosted an illuminating panel presentation on Life Sciences Litigation: A Look at Milestone Disputes & Recent Trends. Panelists included Lauri Mims and Jennifer Huber, both Partners at Keker Van...more
5/20/2022
/ Acquisitions ,
Biotechnology ,
Business Valuations ,
Buyers ,
Contract Drafting ,
Contract Negotiations ,
Contract Terms ,
Earn-Outs ,
Life Sciences ,
Mergers ,
Milestone Payments ,
Pharmaceutical Industry ,
Research and Development ,
Sellers